Carmel Rice

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus et al. · The Lancet Haematology · 2022 · 121 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cell Therapy +10

Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors

Ana M. Metelo, Agnieszka Jóźwik, Le Anh Luong et al. · Cancer Research Communications · 2022 · 39 citations · Full text

Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia

Carmel Rice, Dirk-Jan Eikema, Judith Marsh et al. · Biology of Blood and Marrow Transplantation · 2018 · 36 citations · Full text

Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells

Francesco Grimaldi, Victoria Potter, Pilar Perez-Abellan et al. · Biology of Blood and Marrow Transplantation · 2016 · 34 citations · Full text

Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)

P.D. Miller, John A. Snowden, Régis Peffault de Latour et al. · Bone Marrow Transplantation · 2019 · 31 citations · Full text

Immunology, Pathology, Immunotherapy +18